Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H2KL
|
|||
| Drug Name |
PMID29338548-Compound-13
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Schizophrenia [ICD-11: 6A20] | Patented | [1] | |
| Company |
GLAXO GROUP LIMITED BRADLEY, Daniel, Marcus BRANCH, Clive, Leslie CHAN, Wai, Ngor COULTON, Steven GILPIN, Martin, Leonard HARRIS, Andrew, Jonathan JAXA-CHAMIEC, Albert, Andrzej LAI, Justine, Yeun, Quai MARSHALL, Howard, Robert MACRITCHIE, Jacqueline, Anne NASH, David, John PORTER, Roderick, Alan SPADA, Simone THEWLIS, Kevin, Michael WARD, Simon, Edward
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glycine transporter GlyT-1 (SLC6A9) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Glycine transporter GlyT-1 (SLC6A9) | Target's Patent Info | [1] | |
| Reactome | Na+/Cl- dependent neurotransmitter transporters | |||
| WikiPathways | NRF2 pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Glycine transporter-1 inhibitors: a patent review (2011-2016).Expert Opin Ther Pat. 2018 Mar;28(3):197-210. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.